Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer - Lee, Chun-Hui; Hsieh, Jason Chia-Hsun; Wu, Tyler Min-Hsien; Yeh, Ting-Shiuan; Wang, Hung-Ming; Lin, Yung-Chan; Chen, Jen-Shi; Lee, Chia-Lin; Huang, Wen-Kuan; Hung, Tsung-Min; Yen, Tzu-Tsen; Chan, Sheng-Chieh; et al. (BMC cancer, 2019)
Keywords: AC133 Antigen - immunology; Adult; Aged; Aged, 80 and over; Blood; Breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - mortality; Breast Neoplasms - pathology; Cancer metastasis; Cancer research; Cancer stem cells; Cancer therapies; Cancer treatment; Carcinoma; Carcinoma, Ductal, Breast - drug therapy; Carcinoma, Ductal, Breast - mortality; Carcinoma, Ductal, Breast - pathology; CD133; CD45 antigen; Cell adhesion & migration; Cell Count; Chemotherapy; Circulating tumor cells; Endocrine therapy; Female; Flow cytometry; Humans; Invasive ductal carcinoma (Breast cancer); Invasiveness; Liquid Biopsy; Medical research; Metastases; Metastasis; Middle Aged; Multivariate analysis; Negative selection; Neoplastic Cells, Circulating - immunology; Neoplastic Cells, Circulating - pathology; Neoplastic Stem Cells - immunology; Neoplastic Stem Cells - pathology; Patient outcomes; Patients; Prognosis; Prospective Studies; Stem cell research; Stem cells; Studies; Survival Analysis; Treatment Outcome; Tumor cells; Tumors; United States--US; Taiwan; Chemotherapy; Breast cancer; Circulating tumor cells; Cancer stem cells; CD133